The lawsuit was filed against the government, Health Ministry, former Health Minister Khairy Jamaluddin, former Director-General of Health Tan Sri Dr Noor Hisham Abdullah, and three Covid-19 vaccine producers: Pfizer, AstraZeneca, and Pharmaniaga. - NSTP file pic
The lawsuit was filed against the government, Health Ministry, former Health Minister Khairy Jamaluddin, former Director-General of Health Tan Sri Dr Noor Hisham Abdullah, and three Covid-19 vaccine producers: Pfizer, AstraZeneca, and Pharmaniaga. - NSTP file pic

KUALA LUMPUR: A lawsuit involving claims of side effects from Covid-19 vaccine filed against the government, Health Ministry (MOH), and former Health minister will be heard today.

The scheduled hearing for the related lawsuit is set to take place at the High Court here via a video conference at 9 am.

Besides the government and MOH, the lawsuit also involves former Health Minister Khairy Jamaluddin Abu Bakar, former Director-General of Health Tan Sri Dr Noor Hisham Abdullah, and three Covid-19 vaccine producers: Pfizer, AstraZeneca, and Pharmaniaga.

In a Nov 2022 statement, lawyers representing all plaintiffs asserted that the group alleged the MOH issued an invalid declaration and coerced agreement by the defendants to shield them from being held accountable for severe Covid-19 vaccine injection side effects.

The plaintiffs demanded that the defendants be held responsible for the side effects of the Covid-19 vaccine injections, including severe complications leading to death, permanent disability, and other complications resulting in losses.

They also seek general and special damages that the defendants must pay due to the aforementioned side effects.

Moreover, the plaintiffs insisted on all subsequent vaccines undergoing clinical trials, with complete reports on the effectiveness of the Covid-19 vaccines in controlling the pandemic's transmission.

The plaintiffs also called for a temporary restriction on administering the Covid-19 vaccine to Malaysians until clinical studies are conducted with detailed reports presented.